RT Journal Article
SR Electronic
T1 Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 70
DO 10.1186/s40425-019-0538-8
VO 7
IS 1
A1 Erbe, Amy K.
A1 Wang, Wei
A1 Carmichael, Lakeesha
A1 Hoefges, Anna
A1 Grzywacz, Bartosz
A1 Reville, Patrick K.
A1 Ranheim, Erik A.
A1 Hank, Jacquelyn A.
A1 Kim, KyungMann
A1 Seo, Songwon
A1 Mendonca, Eneida A.
A1 Song, Yiqiang
A1 Kenkre, Vaishalee P.
A1 Hong, Fangxin
A1 Gascoyne, Randy D.
A1 Paietta, Elisabeth
A1 Horning, Sandra J.
A1 Miller, Jeffrey S.
A1 Kahl, Brad
A1 Sondel, Paul M.
YR 2019
UL http://jitc.bmj.com/content/7/1/70.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.